$706.94
At close: Feb 26, 4:00 PM EDT
$706.94
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Regeneron Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:REGN | Benzinga
Regeneron Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$10.260
Quarterly Revenue Estimate
$3.48B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$14.20B
Analyze the earnings history of Regeneron Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Regeneron Pharmaceuticals (REGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-04 | $12.07 | $11.19 | 7.86 % |
| Q3 | 2024-10-31 | $12.46 | $11.69 | 6.59 % |
| Q2 | 2024-08-01 | $11.56 | $10.53 | 9.78 % |
| Q1 | 2024-05-02 | $9.55 | $10.10 | -5.45 % |
Regeneron Pharmaceuticals (REGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-04 | $3.79B | $3.75B | 1.04 % |
| Q3 | 2024-10-31 | $3.72B | $3.67B | 1.39 % |
| Q2 | 2024-08-01 | $3.55B | $3.36B | 5.57 % |
| Q1 | 2024-05-02 | $3.15B | $3.22B | -2.33 % |
FAQ
When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?
Regeneron Pharmaceuticals (REGN) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 4, 2025 for Q4.
What were the latest earnings per share (EPS) for Regeneron Pharmaceuticals (NASDAQ:REGN)?
The Actual EPS was $12.07, which beat the estimate of $11.19.
What were Regeneron Pharmaceuticals’s (NASDAQ:REGN) revenues?
The Actual Revenue was $3.8B, which beat the estimate of $3.8B.
Browse earnings estimates, EPS, and revenue on all stocks.